Who
Matthew E. Ros
Chief Operating Officer
Company insider
Files Form 4 as: Chief Operating Officer, Jasper Therapeutics; Senior VP, Commercial Ops, Ariad Pharmaceuticals.
In numbers
- Trades disclosed
- 3
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 22 Mar 2010
- Last trade
- 20 Jul 2026
- Last filed
- 22 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Jul 2026filed 22 Jul 2026 | JSPR Jasper Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code P | —881 | filing |
| 20 Jul 2026filed 22 Jul 2026 | JSPR Jasper Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code P | —881 | filing |
| 22 Mar 2010filed 24 Mar 2010 | Ariad Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —79,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.